BIO-K+ CL1285 for Prevention of Recurrent Clostridium Difficile Infection

计划入组 140 人 · 首次发布于 2010 年 9 月 16 日

Application of the autologous CAR T cells (Tarcidomgen Kimleucel) in the treatment of refractory and relapsed CD19+ B cell neoplasms

计划入组 6 人 · 首次发布于 2025 年 1 月 30 日

Efficacy of BIO-K+ CL1285® Prophylaxis in the Prevention of Traveler's Diarrhea in Adults

计划入组 277 人 · 首次发布于 2008 年 8 月 19 日

CL18/6

Mcl1

C11

CLS PHARMA

France

German CLL Study Group

Germany

CL AVIATION, INC.

United States

Cortical Labs Launches World's First Commercial Biological Computer, Ushering in Synthetic Intelligence

DayOne Launches Singapore's First Biological Data Center Prototype with Cortical Labs and NUS Medicine

Liso-cel Plus Ibrutinib Shows Promise in Relapsed/Refractory CLL/SLL: Primary Results from TRANSCEND CLL 004 Study